Quantcast
Channel: Becker's Spine Review
Viewing all articles
Browse latest Browse all 23847

U.S. Spinal Fusion Market Share to Drop 8% by 2020; China to Grow 5%

$
0
0

A new report from Research and Markets shows the United States spinal fusion market share will shrink over the next few years.

While the United States will continue to occupy the majority of the spinal fusion market through 2020, the country's global market share will decline from 71 percent last year to 63 percent in 2020. The United States is also expected to experience one of the lowest growth rates over the next six years because the market recently matured and new reimbursement hurdles from public payers.

 

Coverage policies for spinal fusion are changing across the country; this past week, a Kansas news source reported that since the Blue Cross and Blue Shield of Kansas made spinal fusion coverage changes last year, patients feel their access to care has been limited.

 

Emerging markets will drive global growth; China is expected to have double-digit growth rates through 2020 and will increase its market share from 5 percent in 2013 to 10 percent in 2020. Factors contributing to this growth include rapid advancement in access to medical treatment and new less invasive techniques; and more people are financially able to pay for these procedures than in the past.

 

The 2013 spinal fusion market was valued at $4.7 billion across 10 major regions covered, including the United States, France, Germany, Italy, Spain, United Kingdom, Japan, Brazil, India and China. The report forecasted out to 2020, when the market is expected to reach $6.9 billion with a compound annual growth rate of 5.58 percent. At the same time, the spinal non-fusion market is expected to triple in size through, but projections place it at $1.6 billion, according to the Millennium Research Group report.

 

A growing trend in artificial disc replacement is now backed by the literature, and the AMA CPT panel granted two-level cervical disc replacements a Category I code beginning in 2015. LDR's Mobi-C artificial disc is currently the only disc FDA cleared for two-level procedures.

 

More Articles on Spine Surgery:
5 Observations on Spinal Fusion Market Analysis
Spine Surgery in ASCs: 6 Burning Questions About Future Feasibility
8 Core Concepts for Cutting-Edge Comprehensive Spine Practices Today


Viewing all articles
Browse latest Browse all 23847

Trending Articles